Feedback
Madhukar Pai | Ideas for India

Madhukar Pai
McGill University
madhukar.pai@mcgill.ca
Prof. Madhukar Pai (MD, PhD, FCAHS) is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB (tuberculosis) Centre.

Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his Ph.D. in epidemiology at University of California, Berkeley, and a postdoctoral fellowship at the University of California, San Francisco.

Madhu serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the STAG-TB (Strategic and Technical Advisory Group for Tuberculosis) committee of WHO, Geneva; Scientific Advisory Committee of FIND (Foundation for Innovative New Diagnostics), Geneva; and Access Advisory Committee of TB Alliance, New York. He serves as the Chair of the Public-Private Mix (PPM) Working Group of the Stop TB Partnership. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, eLife, PLoS ONE, International Journal of TB and Lung Disease, among others.

Madhu’s research is mainly focussed on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries like India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada, and Canadian Institutes of Health Research. He has more than 300 publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award, Haile T. Debas Prize, and David Johnston Faculty & Staff Award. He is a member of the Royal Society of Canada, and a Fellow of the Canadian Academy of Health Sciences.

Articles By Madhukar Pai
India's plan to eliminate tuberculosis by 2025: Converting rhetoric into reality
Posted On: 24 Jan 2018

Topics:   Health

During the 2017 Union Budget address, the Government of India announced its plan to eliminate tuberculosis (TB) by 2025, which is extraordinarily ambitious given that India accounts for a large proportion of new TB cases and deaths globally. In this article, Pai, Bhaumik, and Bhuyan offer some suggestions that might help bridge the gap between ambition and reality.
read on »

Most Read

Twitter Feed